title: Is vasopressin increasing or decreasing mortality in patients with septic shock?
authors.forename: Sebastian
authors.initials: S
authors.lastname: Rehberg
authors.forename: Christian
authors.initials: C
authors.lastname: Ertmer
authors.forename: Hugo
authors.initials: H
authors.lastname: Van Aken
authors.forename: Martin
authors.initials: M
authors.lastname: Westphal
mesh_terms: D004359:Drug Therapy, Combination; D006801:Humans; D009638:Norepinephrine / Q000627:therapeutic use; D012772:Shock, Septic / Q000188:drug therapy* / Q000401:mortality; D016019:Survival Analysis; D014662:Vasoconstrictor Agents / Q000009:adverse effects*; D014667:Vasopressins / Q000009:adverse effects*
chemical_list: D014662:Vasoconstrictor Agents; D014667:Vasopressins; D009638:Norepinephrine